Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming

Impacto

Downloads

Downloads per month over past year

Angelina Querencias, Alba and Pérez Diego, Mario and López Abente, Jacobo and Rückert, Beate and Nombela, Iván and Akdis, Mübeccel and Martín Fontecha, María del Mar and Akdis, Cezmi A. and Palomares, Oscar (2021) Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming. Mucosal Immunology, 15 . pp. 96-108. ISSN 1933-0219

[thumbnail of s41385-021-00455-x.pdf]
Preview
PDF
Creative Commons Attribution.

4MB

Official URL: https://doi.org/10.1038/s41385-021-00455-x




Abstract

The generation of functional regulatory T cells (Tregs) is essential to keep tissue homeostasis and restore healthy immune responses in many biological and inflammatory contexts. Cannabinoids have been pointed out as potential therapeutic tools for several diseases. Dendritic cells (DCs) express the endocannabinoid system, including the cannabinoid receptors CB1 and CB2. However, how cannabinoids might regulate functional properties of DCs is not completely understood. We uncover that the triggering of cannabinoid receptors promote human tolerogenic DCs that are able to prime functional FOXP3+ Tregs in the context of different inflammatory diseases. Mechanistically, cannabinoids imprint tolerogenicity in human DCs by inhibiting NF-κB, MAPK and mTOR signalling pathways while inducing AMPK and functional autophagy flux via CB1- and PPARα-mediated activation, which drives metabolic rewiring towards increased mitochondrial activity and oxidative phosphorylation. Cannabinoids exhibit in vivo protective and anti-inflammatory effects in LPS-induced sepsis and also promote the generation of FOXP3+ Tregs. In addition, immediate anaphylactic reactions are decreased in peanut allergic mice and the generation of allergen-specific FOXP3+ Tregs are promoted, demonstrating that these immunomodulatory effects take place in both type 1- and type 2-mediated inflammatory diseases. Our findings might open new avenues for novel cannabinoid-based interventions in different inflammatory and immune-mediated diseases.


Item Type:Article
Additional Information:

Received: 5 May 2021 / Revised: 4 August 2021 / Accepted: 7 September 2021 / Published online: 21 September 2021.

Uncontrolled Keywords:Regulatory T-cells; Human dendritic cells; Activation; MTOR; AMPK; Mechanisms; Responses; Differentiation; Expression; Capacity
Subjects:Medical sciences > Biology > Cytology
Medical sciences > Biology > Molecular biology
Medical sciences > Biology > Biochemistry
ID Code:68062
Deposited On:24 Feb 2022 11:42
Last Modified:24 Feb 2022 12:58

Origin of downloads

Repository Staff Only: item control page